TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in SarcopeniaFrailty Induced by GLP-1 Weight Loss Drugs
| TNFA Stock | 1.29 0.07 5.15% |
About 62% of TNF Pharmaceuticals,'s investor base is looking to short. The analysis of overall sentiment of trading TNF Pharmaceuticals, stock suggests that many investors are alarmed at this time. The current market sentiment, together with TNF Pharmaceuticals,'s historical and current headlines, can help investors time the market. In addition, many technical investors use TNF Pharmaceuticals, stock news signals to limit their universe of possible portfolio assets.
TNF |
TNF Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company committed to developing novel oral ther
Read at businesswire.com
 |
TNF Pharmaceuticals, Fundamental Analysis
We analyze TNF Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TNF Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TNF Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
TNF Pharmaceuticals, is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
TNF Pharmaceuticals, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TNF Pharmaceuticals, stock to make a market-neutral strategy. Peer analysis of TNF Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing TNF Pharmaceuticals, by comparing valuation metrics with similar companies.
Peers
TNF Pharmaceuticals, Related Equities
| GLUE | Monte Rosa | 3.03 | ||||
| EPIX | ESSA Pharma | 1.87 | ||||
| NUVB | Nuvation Bio | 1.49 | ||||
| ORIC | Oric Pharmaceuticals | 1.46 | ||||
| SNSE | Sensei Biotherapeutics | 0.44 | ||||
| DSGN | Design Therapeutics | 0.64 | ||||
| INBX | Inhibrx | 0.89 | ||||
| ERAS | Erasca | 2.36 | ||||
| LYRA | Lyra Therapeutics | 2.83 | ||||
| NXTC | NextCure | 2.99 |
Complementary Tools for TNF Stock analysis
When running TNF Pharmaceuticals,'s price analysis, check to measure TNF Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TNF Pharmaceuticals, is operating at the current time. Most of TNF Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of TNF Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TNF Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of TNF Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |